Contact this trialFirst, we need to learn more about you.
PI3K-Beta Inhibitor
GSK2636771 + Pembrolizumab for Metastatic Melanoma
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is studying a combination of drugs as a possible treatment for melanoma that has spread to other parts of the body and has not responded to other treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.